Injectafer Approval History
- FDA approved: Yes (First approved July 25th, 2013)
- Brand name: Injectafer
- Generic name: ferric carboxymaltose
- Company: Luitpold Pharmaceuticals, Inc.
- Treatment for: Iron Deficiency Anemia
Injectafer (ferric carboxymaltose) is an iron replacement product indicated for the treatment of iron deficiency anemia.
FDA Approval History for Injectafer
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.